You are here » Home » Companies » Company Overview » Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd.

BSE: 532305 Sector: Health care
NSE: INDSWFTLAB ISIN Code: INE915B01019
BSE LIVE 15:28 | 06 Dec 36.15 -0.30
(-0.82%)
OPEN

39.00

HIGH

39.00

LOW

36.00

NSE LIVE 15:49 | 06 Dec 36.35 -0.05
(-0.14%)
OPEN

37.40

HIGH

37.50

LOW

36.20

OPEN 39.00
PREVIOUS CLOSE 36.45
VOLUME 18510
52-Week high 56.20
52-Week low 30.55
P/E
Mkt Cap.(Rs cr) 149.95
Buy Price 36.15
Buy Qty 50.00
Sell Price 36.40
Sell Qty 50.00
OPEN 39.00
CLOSE 36.45
VOLUME 18510
52-Week high 56.20
52-Week low 30.55
P/E
Mkt Cap.(Rs cr) 149.95
Buy Price 36.15
Buy Qty 50.00
Sell Price 36.40
Sell Qty 50.00

About Ind-Swift Laboratories Ltd.

Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India. The company manufactures and sells active pharmaceutical ingredients (API). Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (a...> More

Ind-Swift Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   150
EPS - TTM () [*S] -
P/E Ratio (X) [*S] -
Face Value ()   10
Latest Dividend (%)   10.00
Latest Dividend Date 20 Sep 2011
Dividend Yield (%) 0.00
Book Value / Share () [*S] 48.97
P/B Ratio () [*S] 0.74
[*C] Consolidated     [*S] Standalone

Ind-Swift Laboratories Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 170.12 163.74 3.9
Other Income 1.35 3.46 -60.98
Total Income 171.47 167.21 2.55
Total Expenses 141.29 135.76 4.07
Operating Profit 30.18 31.45 -4.04
Net Profit -14.43 -15.7 8.09
Equity Capital 41.48 40.96 -
> More on Ind-Swift Laboratories Ltd Financials Results

Ind-Swift Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Syncom Formul. 2.21 -2.21 172.53
DIL 745.65 -2.91 170.75
Bajaj Healthcare 239.00 3.91 164.91
Ind-Swift Labs. 36.15 -0.82 149.95
Bal Pharma 99.10 -1.25 140.42
Wintac 140.10 1.78 140.38
Zenotech Lab. 39.95 0.00 137.55
> More on Ind-Swift Laboratories Ltd Peer Group

Ind-Swift Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 52.00
Banks/FIs 0.07
FIIs 2.74
Insurance 0.00
Mutual Funds 0.00
Indian Public 35.45
Custodians 0.00
Other 9.74
> More on Ind-Swift Laboratories Ltd Share Holding Pattern

Ind-Swift Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -3.08% -2.68% 0.00% 0.01%
1 Month -12.04% -11.66% -3.23% -3.45%
3 Month -0.28% 0.69% -8.92% -8.94%
6 Month -12.15% -11.66% -1.44% -0.71%
1 Year 5.55% 6.13% 2.94% 4.64%
3 Year 28.65% 29.36% 25.70% 30.08%

Ind-Swift Laboratories Ltd - STOCK STRENGTH

Today's Low/High 36.00
39.00
Week Low/High 36.00
40.00
Month Low/High 33.60
43.00
YEAR Low/High 30.55
56.00
All TIME Low/High 13.25
297.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard